We are a medical device company developing a proprietary technology platform for cardiac electrophysiology procedures.
The PURE EP™ System, our first product under development, is a novel cardiac EP recording and analysis system.
We believe our platform will significantly enhance the capabilities of cardiologists and the outcome of EP procedures.
We are developing the PURE EP System, a multichannel electrocardiogram and intracardiac multichannel recording and analysis system. We believe that data provided by the PURE EP System will increase the workload ability and enhance the capabilities of the typical electrophysiology laboratory.
We are focused on improving the quality of cardiac recordings obtained during cardiac catheter ablation of ventricular tachycardia and atrial fibrillation, two common cardiac arrhythmias. Cardiac ablation is a procedure performed to correct conduction of electrical impulses in the heart that cause arrhythmias.
Our overall goal is to establish this proprietary technology as a new platform that will have the following advantages over the electrophysiology recording systems currently available on the market: